María Angélica Cortez

Author

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

A8 Clarke, M A Cortez, M Angelica Cortez, M Cortez, M. Angelica Cortez, M.A. Cortez, M.A.A. Cortez, Maria A Cortez, Maria A. A. Cortez, Maria A. Cortez

238

Publications

9.5K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Shandong First Medical University Shandong Tumor Hospital Koç University Allegheny General Hospital

About

María Angélica Cortez is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	18	2.1K
2	Immunology	9	9	1.4K
3	Cell Biology	8	8	1.4K
4	Health Sciences	4	4	363
5	Cellular Physiology	1	1	21

María Angélica Cortez

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression Limo Chen, Don L. Gibbons, Sangeeta Goswami, Nature Communications Intratumoral ImmunosuppressionMicrorna-200/zeb1 Axis ControlMedicineImmunologyTumor Immunity	2014	970
Co-occurring Genomic Alterations Define Major Subsets of <i>KRAS</i> -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities Ferdinandos Skoulidis, Lauren A. Byers, Lixia Diao, Cancer Discovery	2015	883
PDL1 Regulation by p53 via miR-34 María Angélica Cortez, Cristina Ivan, David R. Valdecanas, JNCI Journal of the National Cancer Institute	2015	657
Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy Xiaohong Wang, Jonathan E. Schoenhals, Ailin Li, Cancer Research	2016	264
Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma Hampartsoum B. Barsoumian, Rishab Ramapriyan, Ahmed Younes, Journal for ImmunoTherapy of Cancer	2020	199
Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer María Angélica Cortez, David R. Valdecanas, Xiaochun Zhang, Molecular Therapy Mir-200 MirnasOncogenic AgentMedicineBronchial NeoplasmOxidative Stress Response	2014	192
Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses James W. Welsh, Chad Tang, Patricia M. de Groot, Cancer Immunology Research	2019	141
Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR Carlos Alberto Scrideli, Carlos Gilberto Carlotti, Oswaldo Keith Okamoto, Journal of Neuro-Oncology Neuro-oncologyReal-time Quantitative PcrGliomaTumor HeterogeneityOligonucleotide Microarray	2008	132
<i>miR‐29b</i> and <i>miR‐125a</i> regulate podoplanin and suppress invasion in glioblastoma María Angélica Cortez, Milena S. Nicoloso, Masayoshi Shimizu, Genes Chromosomes and Cancer	2010	131
Absolute Lymphocyte Count Predicts Abscopal Responses and Outcomes in Patients Receiving Combined Immunotherapy and Radiation Therapy: Analysis of 3 Phase 1/2 Trials Dawei Chen, Vivek Verma, Roshal R. Patel, International Journal of Radiation OncologyBiologyPhysics Phase 1/2Lymphoid NeoplasiaCancer ImmunosurveillanceRadiation TherapyMedicine	2020	127

Page 1